On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that medicines, supplied in the context of the fulfilment of public service obligations, intended for Belgian patients, are distributed to other countries.
The letter published by FAMHP provides an overview of the practical impact for the stakeholders involved and can be found here.
More information about the amendment of the law can be found here.